Multicenter Study of Risk-Adapted Therapy With Dose-Adjusted EPOCH-R in Adults With Untreated Burkitt Lymphoma

PURPOSE: Burkitt lymphoma is an aggressive B-cell lymphoma curable with dose-intensive chemotherapy derived from pediatric leukemia regimens. Treatment is acutely toxic with late sequelae. We hypothesized that dose-adjusted etoposide, doxorubicin, cyclophosphamide, vincristine, prednisone, and ritux...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Clin Oncol
Main Authors: Roschewski, Mark, Dunleavy, Kieron, Abramson, Jeremy S., Powell, Bayard L., Link, Brian K., Patel, Prapti, Bierman, Philip J., Jagadeesh, Deepa, Mitsuyasu, Ronald T., Peace, David, Watson, Peter R., Hanna, Wahid T., Melani, Christopher, Lucas, Andrea N., Steinberg, Seth M., Pittaluga, Stefania, Jaffe, Elaine S., Friedberg, Jonathan W., Kahl, Brad S., Little, Richard F., Bartlett, Nancy L., Fanale, Michelle A., Noy, Ariela, Wilson, Wyndham H.
Format: Artigo
Jezik:Inglês
Izdano: American Society of Clinical Oncology 2020
Teme:
ORIGINAL REPORTS
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7392744/
https://ncbi.nlm.nih.gov/pubmed/32453640
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.20.00303
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki